首页> 外文OA文献 >Solution Structure of the Squash Aspartic Acid Proteinase Inhibitor (SQAPI) and Mutational Analysis of Pepsin Inhibition
【2h】

Solution Structure of the Squash Aspartic Acid Proteinase Inhibitor (SQAPI) and Mutational Analysis of Pepsin Inhibition

机译:南瓜天冬氨酸蛋白酶抑制剂(SQAPI)的溶液结构和胃蛋白酶抑制的突变分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The squash aspartic acid proteinase inhibitor (SQAPI), a proteinaceous proteinase inhibitor from squash, is an effective inhibitor of a range of aspartic proteinases. Proteinaceous aspartic proteinase inhibitors are rare in nature. The only other example in plants probably evolved from a precursor serine proteinase inhibitor. Earlier work based on sequence homology modeling suggested SQAPI evolved from an ancestral cystatin. In this work, we determined the solution structure of SQAPI using NMR and show that SQAPI shares the same fold as a plant cystatin. The structure is characterized by a four-strand anti-parallel β-sheet gripping an α-helix in an analogous manner to fingers of a hand gripping a tennis racquet. Truncation and site-specific mutagenesis revealed that the unstructured N terminus and the loop connecting β-strands 1 and 2 are important for pepsin inhibition, but the loop connecting strands 3 and 4 is not. Using ambiguous restraints based on the mutagenesis results, SQAPI was then docked computationally to pepsin. The resulting model places the N-terminal strand of SQAPI in the S′ side of the substrate binding cleft, whereas the first SQAPI loop binds on the S side of the cleft. The backbone of SQAPI does not interact with the pepsin catalytic Asp32–Asp215 diad, thus avoiding cleavage. The data show that SQAPI does share homologous structural elements with cystatin and appears to retain a similar protease inhibitory mechanism despite its different target. This strongly supports our hypothesis that SQAPI evolved from an ancestral cystatin.
机译:壁球天冬氨酸蛋白酶抑制剂(SQAPI)是一种来自壁球的蛋白质蛋白酶抑制剂,是多种天冬氨酸蛋白酶的有效抑制剂。蛋白质天冬氨酸蛋白酶抑制剂在自然界中是罕见的。植物中唯一的其他例子可能是从前体丝氨酸蛋白酶抑制剂演变而来的。基于序列同源性建模的早期工作表明SQAPI是从祖先的胱抑素演变而来的。在这项工作中,我们使用NMR确定了SQAPI的溶液结构,并表明SQAPI与植物半胱氨酸蛋白酶抑制剂具有相同的折叠倍数。该结构的特征在于,四股反平行的β-折叠片以与抓网球拍的手的手指类似的方式夹持α-螺旋。截短和位点特异性诱变显示,非结构化的N末端以及连接β链1和2的环对于胃蛋白酶抑制很重要,但是连接3和4的环并不重要。使用基于诱变结果的模棱两可的限制,然后将SQAPI通过计算对接至胃蛋白酶。所得模型将SQAPI的N末端链放置在底物结合裂隙的S'侧,而第一个SQAPI环结合在裂隙的S侧。 SQAPI的主链不与胃蛋白酶催化的Asp32–Asp215双价相互作用,从而避免裂解。数据表明,SQAPI与半胱氨酸蛋白酶抑制剂确实具有同源的结构元件,尽管其靶标不同,但似乎保留了相似的蛋白酶抑制机制。这有力地支持了我们的假设,即SQAPI从祖先的胱抑素进化而来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号